This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yuanzhi Chen and Patent Innovation in Antibody Research.
Introduction
Yuanzhi Chen is an inventor based in Houston, Texas. His patent work includes research on monoclonal antibodies targeting LILRB1, a subject with potential diagnostic and therapeutic applications.
Latest Patents
Chen is associated with 1 patent: “MONOCLONAL ANTIBODIES AGAINST LILRB1 FOR DIAGNOSTIC AND THERAPEUTIC USE.” The patent concerns antibodies directed against LILRB1 and their possible use in diagnosis and treatment.
Career Highlights
Chen’s listed patent is associated with The University of Texas System. It reflects his contribution to intellectual property related to antibody-based research.
Collaborations
The University of Texas System is identified as the organization associated with Chen’s patent. The available information does not specify additional collaborators.
Conclusion
Yuanzhi Chen’s patent on monoclonal antibodies against LILRB1 represents his documented contribution to diagnostic and therapeutic innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile